{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T01:56:48Z","timestamp":1787968608064,"version":"build-2784847793"},"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2015,9,29]],"date-time":"2015-09-29T00:00:00Z","timestamp":1443484800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0138107","type":"journal-article","created":{"date-parts":[[2015,9,29]],"date-time":"2015-09-29T13:57:55Z","timestamp":1443535075000},"page":"e0138107","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":35,"title":["Visualization of Active Glucocerebrosidase in Rodent Brain with High Spatial Resolution following In Situ Labeling with Fluorescent Activity Based Probes"],"prefix":"10.1371","volume":"10","author":[{"given":"Daniela","family":"Herrera Moro Chao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter W.","family":"Kallemeijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre R. A.","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Orre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roelof","family":"Ottenhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"van Roomen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewout","family":"Foppen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C.","family":"Renner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Moeton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"van Eijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf G.","family":"Boot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem","family":"Kamphuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elly M.","family":"Hol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Aten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermen S.","family":"Overkleeft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andries","family":"Kalsbeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes M. F. G.","family":"Aerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,9,29]]},"reference":[{"key":"ref1","first-page":"3635","article-title":"Gaucher disease, The Metabolic and Molecular Bases of Inherited Disease","author":"E Beutler","year":"2001"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0925-4439(93)90090-N","article-title":"Demonstration of the existence of a second, non-lysosomal glucocerebrosidase that is not deficient in Gaucher disease","volume":"1181","author":"S van Weely","year":"1993","journal-title":"Biochim Biophys Acta"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ymgme.2010.12.014","article-title":"Accumulation and distribution of \u03b1-synuclein and ubiquitin in the CNS of Gaucher disease mouse models","volume":"102","author":"YH Xu","year":"2011","journal-title":"Mol Genet Metab"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ymgme.2004.04.011","article-title":"Neuropathology provides clues to the pathophysiology of Gaucher disease","volume":"82","author":"K Wong","year":"2004","journal-title":"Mol Genet Metab"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.molmed.2011.05.003","article-title":"Exploring the link between glucocerebrosidase mutations and Parkinsonism","volume":"17","author":"W Westbroek","year":"2011","journal-title":"Trends Mol Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/ana.23614","article-title":"Glucocerebrosidase deficiency in substantia nigra of Parkinson disease brains","volume":"72","author":"ME Gegg","year":"2012","journal-title":"Ann Neurol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ymgme.2003.11.004","article-title":"Glucocerebrosidase mutations in subjects with Parkinsonism","volume":"81","author":"A Lwin","year":"2004","journal-title":"Mol Genet Metab"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1093\/brain\/awu002","article-title":"Glucocerebrosidase is shaking up the synucleinopathies","volume":"137","author":"M Siebert","year":"2014","journal-title":"Brain"},{"key":"ref9","article-title":"Glucocerebrosidase and Parkinson disease: Recent advances","author":"AH Schapira","year":"2015","journal-title":"Mol Cell Neurosci"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.pneurobio.2014.12.001","article-title":"Gaucher-related synucleinopathies: the examination of sporadic neurodegeneration from a rare (disease) angle","volume":"125","author":"SP Sardi","year":"2015","journal-title":"Prog Neurobiol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.neuro.2009.06.009","article-title":"Alpha-synuclein-glucocerebrosidase interactions in pharmacological Gaucher models: A biological link between Gaucher disease and parkinsonism","volume":"30","author":"AB Manning-Bo\u011f","year":"2009","journal-title":"Neurotoxicology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2011.06.001","article-title":"Gaucher disease glucocerebrosidase and \u03b1-synuclein form a bidirectional pathogenic loop in synucleinopathies","volume":"146","author":"JR Mazzulli","year":"2011","journal-title":"Cell"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"12101","DOI":"10.1073\/pnas.1108197108","article-title":"CNS expression of glucocerebrosidase corrects alpha-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy","volume":"108","author":"SP Sardi","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000335038","article-title":"Mutant GBA1 expression and synucleinopathy risk: first insights from cellular and mouse models","volume":"10","author":"SP Sardi","year":"2012","journal-title":"Neurodegener Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.cell.2007.10.018","article-title":"LIMP-2 is a receptor for lysosomalmannose-6-phosphate-independent targeting of beta-glucocerebrosidase","volume":"131","author":"D Reczek","year":"2007","journal-title":"Cell"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"15573","DOI":"10.1073\/pnas.1405700111","article-title":"LIMP-2 expression is critical for \u03b2-glucocerebrosidase activity and \u03b1-synuclein clearance","volume":"111","author":"M Rothaug","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM199105233242104","article-title":"Replacement therapy for inherited enzyme deficiency\u2014macrophage-targeted glucocerebrosidase for Gaucher&apos;s disease","volume":"324","author":"NW Barton","year":"1991","journal-title":"N Engl J Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0140-6736(00)02161-9","article-title":"Novel oral treatment of Gaucher&apos;s disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis","volume":"355","author":"T Cox","year":"2000","journal-title":"Lancet"},{"issue":"15","key":"ref19","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1007\/s40265-014-0296-3","article-title":"Eliglustat: first global approval","volume":"74","author":"RM Poole","year":"2014","journal-title":"Drugs"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"9096","DOI":"10.1021\/jm501181z","article-title":"Identification and development of biphenyl substituted iminosugars as improved dual glucosylceramide synthase\/neutral glucosylceramidase inhibitors","volume":"57","author":"AT Ghisaidoobe","year":"2014","journal-title":"J Med Chem"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nchembio.466","article-title":"Ultrasensitive in situ visualization of active glucocerebrosidase molecules","volume":"6","author":"MD Witte","year":"2010","journal-title":"Nat Chem Biol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s10545-011-9308-6","article-title":"Biomarkers in the diagnosis of lysosomal storage disorders: proteins, lipids, and inhibodies","volume":"34","author":"JM Aerts","year":"2011","journal-title":"J Inherit Metab Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"12529","DOI":"10.1002\/anie.201207771","article-title":"Novel activity-based probes for broad-spectrum profiling of retaining \u03b2-exoglucosidases in situ and in vivo","volume":"51","author":"WW Kallemeijn","year":"2012","journal-title":"Angew Chem Int Ed Engl"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/B978-0-12-800128-8.00004-2","article-title":"Mechanism-based inhibitors of glycosidases: design and applications","volume":"71","author":"WW Kallemeijn","year":"2014","journal-title":"Adv Carbohydr Chem Biochem"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"7786","DOI":"10.1039\/C4OB01611D","article-title":"Exploring functional cyclophellitol analogues as human retaining beta-glucosidase inhibitors","volume":"12","author":"KY Li","year":"2014","journal-title":"Org Biomol Chem"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"10864","DOI":"10.1002\/chem.201404014","article-title":"From covalent glycosidase inhibitors to activity-based glycosidase probes","volume":"20","author":"LI Willems","year":"2014","journal-title":"Chemistry"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"35351","DOI":"10.1074\/jbc.M114.593376","article-title":"A sensitive gel-based method combining distinct cyclophellitol-based probes for the identification of acid\/base residues in human retaining \u03b2-glucosidases","volume":"289","author":"WW Kallemeijn","year":"2014","journal-title":"J Biol Chem"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1039\/C4SC03739A","article-title":"In vitro and in vivo comparative and competitive activity-based protein profiling of GH29 \u03b1-L \u2013fucosidases","volume":"6","author":"J Jiang","year":"2015","journal-title":"Chem Sci"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1432-1033.1985.tb09058.x","article-title":"The occurrence of two immunologically distinguishable beta-glucocerebrosidases in human spleen","volume":"150","author":"JM Aerts","year":"1985","journal-title":"Eur J Biochem"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2013.07.008","article-title":"Acute isolation and transcriptome characterization of cortical astrocytes and microglia from young and aged mice","volume":"35","author":"M Orre","year":"2014","journal-title":"Neurobiol Aging"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1196\/annals.1314.048","article-title":"Localization of mRNA expression of P-glycoprotein at the blood-brain barrier and in the hippocampus","volume":"1032","author":"AM Karssen","year":"2004","journal-title":"Ann NY Acad Sci"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrn1199","article-title":"The role of alpha-synuclein in Parkinson&apos;s disease: insights from animal models","volume":"4","author":"E Maries","year":"2003","journal-title":"Nat Rev Neurosci"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"28080","DOI":"10.1074\/jbc.M111.237859","article-title":"Alpha-synuclein interacts with Glucocerebrosidase providing a molecular link between Parkinson and Gaucher diseases","volume":"286","author":"TL Yap","year":"2011","journal-title":"J Biol Chem"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00401-010-0741-7","article-title":"Glucocerebrosidase is present in \u03b1-synuclein inclusions in Lewy body disorders","volume":"120","author":"O Goker-Alpan","year":"2010","journal-title":"Acta Neuropathol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1093\/hmg\/ddq292","article-title":"Interaction between parkin and mutant glucocerebrosidase variants: A possible link between Parkinson disease and Gaucher disease","volume":"19","author":"I Ron","year":"2010","journal-title":"Hum Mol Genet"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"e1001506","DOI":"10.1371\/journal.pbio.1001506","article-title":"Neuronal expression of glucosylceramide synthase in central nervous system regulates body weight and energy homeostasis","volume":"11","author":"V Nordstr\u00f6m","year":"2013","journal-title":"PLoS Biol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"9691","DOI":"10.1073\/pnas.1103267108","article-title":"Important roles of brain-specific carnitine palmitoyltransferase and ceramidemetabolism in leptin hypothalamic control of feeding","volume":"108","author":"S Gao","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.2337\/db12-1451","article-title":"Hypothalamic ceramide levels regulated by CPT1C mediate the orexigenic effect of ghrelin","volume":"62","author":"S Ram\u00edrez","year":"2013","journal-title":"Diabetes"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nm.3449","article-title":"RIPK3 as a potential therapeutic target for Gaucher&apos;s disease","volume":"20","author":"EB Vitner","year":"2014","journal-title":"Nat Med"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/hmg\/ddt468","article-title":"Neuronal accumulation of glucosylceramide in a mouse model of neuronopathic Gaucher disease leads to neurodegeneration","volume":"23","author":"T Farfel-Becker","year":"2014","journal-title":"Hum Mol Genet"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1172\/JCI29224","article-title":"Mutation of beta-glucosidase 2 causes glycolipid storage disease and impaired male fertility","volume":"116","author":"Y Yildiz","year":"2006","journal-title":"J Clin Invest"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1074\/jbc.M610544200","article-title":"Identification of the non-lysosomal glucosylceramidase as beta-glucosidase 2","volume":"282","author":"RG Boot","year":"2007","journal-title":"J Biol Chem"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ajhg.2012.12.012","article-title":"Mutations in GBA2 cause autosomal-recessive cerebellar ataxia with spasticity","volume":"92","author":"MB Hammer","year":"2013","journal-title":"Am J Hum Genet"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ajhg.2012.11.021","article-title":"Loss of function of glucocerebrosidase GBA2 is responsible for motor neuron defects in hereditary spastic paraplegia","volume":"92","author":"E Martin","year":"2013","journal-title":"Am J Hum Genet"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/PL00007400","article-title":"NACP\/alpha-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson&apos;s disease brains","volume":"99","author":"K Wakabayashi","year":"2000","journal-title":"Acta Neuropathol"},{"key":"ref46","article-title":"Neuroinflammation in Parkinson&apos;s Disease and Related Disorders: A Lesson from Genetically Manipulated Mouse Models of \u03b1-Synucleinopathies","author":"K Sekiyama","year":"2012","journal-title":"Parkinsons Dis"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/brain\/aws095","article-title":"Contribution of brain inflammation to neuronal cell death in neuronopathic forms of Gaucher&apos;s disease","volume":"135","author":"EB Vitner","year":"2012","journal-title":"Brain"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0138107","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T08:27:25Z","timestamp":1540024045000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0138107"}},"subtitle":[],"editor":[{"given":"Patrick","family":"Lewis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,9,29]]},"references-count":47,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2015,9,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0138107","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,29]]}}}